SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-000177
Filing Date
2023-01-03
Accepted
2023-01-03 06:08:04
Documents
14
Period of Report
2022-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d637069d8k.htm   iXBRL 8-K 25180
2 EX-17.1 d637069dex171.htm EX-17.1 1727
3 EX-17.2 d637069dex172.htm EX-17.2 1650
  Complete submission text file 0001193125-23-000177.txt   155631

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vinc-20221230.xsd EX-101.SCH 2838
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20221230_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20221230_pre.xml EX-101.PRE 11699
8 EXTRACTED XBRL INSTANCE DOCUMENT d637069d8k_htm.xml XML 3468
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 23500065
SIC: 2834 Pharmaceutical Preparations